KURA 8-K 2026-01-12

Kura Oncology, Inc. (KURA) 8-K dated 2026-01-12 — accession 0001193125-26-009649. This URL is the filing, not the KURA hub.

Kura Oncology, Inc. (KURA) is a biotechnology company listed on NASDAQ.

Kura Oncology, Inc. filed a 8-K on 2026-01-12. Accession 0001193125-26-009649.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KURA revenue for 2025-12-31 was $67.5M. Net income was -$278.7M. Revenue was up 25.2% from 2024-12-31 to 2025-12-31. KURA currently screens at market cap $861.1M.

Not investment advice. The KURA SEC hub lists recent forms. The stock page is the research view.